Références :
1 - Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, et Al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ.2008;336(7653):1121. Epub 2008 May 14.
2 - Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. Epub 2009 May 19.
3 - Ettehad D, Emdin CA, Kiran A, et Al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957. Epub 2015 Dec 24.
4 - Rosendorff C, Black HR, Cannon CP, et Al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115(21):2761. Epub 2007 May 14.
5 - Mancia G, Fagard R, Narkiewicz K et Al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281.
6 - Xie W, Zheng F, Evangelou E, et Al. Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis. J Hypertens. 2018;36(6):1256.
7 - Thomopoulos C, Parati G, Zanchetti A . Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis. J Hypertens. 2018;36(8):1637.
8 - Multicenter Diltiazem Postinfarction Trial Research Group.The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med. 1988;319(7):385.
9 - Weber MA, Schiffrin EL, White WB et Al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32(1):3.
10 - Messerli FH, Bangalore S, Julius S, Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension.Circulation. 2008;117(20):2706.
11 - Cutler JA, Davis BR. Thiazide-type diuretics and beta-adrenergic blockers as first-line drug treatments for hypertension. Circulation. 2008;117(20):2691.
12 - Wiysonge CS, Bradley HA, Volmink J, et Al. Beta-blockers for hypertension. Cochrane Database Syst Rev. 2012;11:CD002003. Epub 2012 Nov 14
13 - The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 2003; 289:2560.
4 окт 2024
